COVID-19 Request Received
Thank you for getting in touch with us regarding your interest in COVID-19 biosamples. Our team will be in touch as soon as possible.
We remain committed to doing everything we can to support ongoing research in this area, and we appreciate your feedback and participation as we work to deliver the critical research materials you need. Thank you for allowing us to be part of the work you do!
Your source for all things biotech
Stay informed with our expert insights, industry news, and groundbreaking discoveries.
DiaTech Oncology Receives New York State Clinical Laboratory Permit
From the June 25, 2013 press release: DiaTech Oncology, a life sciences and clinical pathology laboratory company based in Nashville,...
Human and Canine Lymphomas Share Molecular Similarities, First Large-Scale Comparison Shows
Taken from the Science Daily article. Humans and their pet dogs are close, so close that they both develop a...
Myriad to Perform BRCA Testing in CDx Deal with Tesaro
Taken from the Genetic Engineering and Biotechnology News clip: Less than two weeks afterthe Supreme Court struck down its gene...
New Palm-Sized Microarray Technique Grows 1,200 Individual Cultures of Microbes
A new palm-sized microarray that holds 1,200 individual cultures of fungi or bacteria could enable faster, more efficient drug discovery,...
Researchers find possible cause of neuron dysfunction in Alzheimer's
From the Fierce Biotech Research article. While the cause and progression ofAlzheimer's diseaseremains unknown, scientists widely accept that amyloid beta...
